Blockchain Registration Transaction Record
Onco-Innovations Merges Biology, Drug Delivery, and AI in Cancer Fight
Onco-Innovations (ONCO, ONNVF) combines PNKP inhibitor ONC010, nanoparticle delivery, and AI from Inka Health to tackle cancer drug resistance, trial failures, and toxicity. Read more.
This news matters because cancer drug development remains plagued by high failure rates, toxicity, and resistance. Onco-Innovations' integrated approach—combining a novel PNKP inhibitor, nanoparticle delivery, and AI-driven trial design—could accelerate the development of more effective and safer therapies. For patients and investors, this represents a potential shift toward smarter, precision-driven oncology that addresses long-standing bottlenecks in the field.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0x2777dcdb1fb861c0675eeaf7989ea48d3aa64246e8ea3e1f9acaf30f331e4113 |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | mail0xcu-41acef5a8e5d9f148fbcf956fceba6ca |